SEC Form 4 · accession 0001209191-18-036906
ALBIREO PHARMA, INC. · ALBO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julia R Brown
Director
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001322505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2018 | M | 1,500 | $18.54 | A | 1,500 | D | |
| Common Stock | Jun 7, 2018 | M | 3,000 | $17.05 | A | 4,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $18.54 | Jun 7, 2018 | M | 1,500 | D | — | Jan 22, 2027 | Common Stock | 1,500 | 3,000 | D |
| Stock Option (right to buy)F2 | $17.05 | Jun 7, 2018 | M | 3,000 | D | — | Jun 15, 2027 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1This option will vest and become exercisable in equal annual installments on the first three anniversaries of the date of grant (but, in any case, to be fully vested on the day prior to the annual meeting for the third fiscal year that begins following the date of grant).
- F2All shares underlying this option have vested.